
Waiel Abusnina (وائل أبوسنينة)
@wabusnina
Muslim, Lifelong learner⚕️Interventional FIT @medStarGUH, former chief cardiology @Creighton, former advanced🫀imaging @universityofky, 🟩 🇱🇾 Posts are my own
ID: 1000710608
https://scholar.google.com/citations?hl=en&user=VwB15VsAAAAJ&view_op=list_works&sortby=pubdate 10-12-2012 02:21:13
1,1K Tweet
1,1K Followers
2,2K Following

Publication in CCIjournal discussing the experience/perspective with intravascular imaging and invasive coronary physiology from allied health professionals. Education and training with the team can build a CCL culture that advocates for both IVI and ICP. pubmed.ncbi.nlm.nih.gov/39219467/



That’s a wrap, TCT Conference! Check out CRTonline for our news coverage on #TCT2024 late-breaking trials. Couldn’t have done it without Kalyan Chitturi, DO, FACC Lior Lupu Dan Haberman Abhishek Chaturvedi MD Waiel Abusnina (وائل أبوسنينة), Natalie, Nathan, Will, and Thomas. Thanks for all your hard work! CRT Meeting





Our results from CMDR suggest a strong association between epicardial fat volume index (a significant risk factor) and the presence of CMD. Waiel Abusnina (وائل أبوسنينة) Ilan Merdler Abhishek Chaturvedi MD Lior Lupu Dan Haberman Itsik Ben Dor Ron Waksman Hayder Hashim JAHA ahajournals.org/doi/10.1161/JA…


The official opening of #CRT2025 🫀 at Washington, DC. Get ready for four days of in-depth education sessions and cutting-edge innovations 👩🔬👨🔬 CRT Meeting #cardiology


Our comprehensive guide recently published in CCIjournal outlines a systematic approach to evaluating CMD, emphasizing practical steps and troubleshooting strategies with case examples to ensure accurate measurements in your real world practice. onlinelibrary.wiley.com/doi/10.1002/cc…


#CRT2025 was a great success. Catch up on all the Late-Breaking Clinical Trials CRT Meeting Jason Galo, MD Abhishek Chaturvedi MD Waiel Abusnina (وائل أبوسنينة) Bailey Salimes Hayder Hashim CRMjournal

A highly practical manuscript 📄focused on closure device-related complications💉, led by Dan Haberman 🌟


Study protocol in the figure..PROTECT IV is a highly anticipated trial that will impact practice Q will it be powered for superiority❓CRMjournal sciencedirect.com/science/articl…

